HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: California Prop 65 public meeting

This article was originally published in The Rose Sheet

Executive Summary

California Prop 65 public meeting: To be held Oct. 29 in Sacramento, Calif. to discuss the inclusion of nitromethane, an ingredient used as a can corrosion inhibitor, in California's "Safe Drinking Water and Toxic Enforcement Act" (Proposition 65) list of chemicals known to cause cancer or reproductive toxicity. Nitromethane is listed in the Cosmetic, Toiletry and Fragrance Association's International Cosmetic Ingredient Dictionary. CTFA noted, however, that there are no reported cosmetic uses for the ingredient. The California Environmental Protection Agency Office of Environmental Health Hazard Assessment is soliciting comments and relevant information to determine the risk of the compound. Comments should be directed to Cynthia Oshita, OEHHA, P.O. Box 942732, Sacramento, Calif., 94234-7320 or faxed at 916/327-1097...

You may also be interested in...

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle

Chart: Weekly Trademark Review -- Nov. 2, 2010

Weekly Trademark Review



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts